Financials Kamada Ltd.

Equities

KMDA

IL0010941198

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE 07:54:13 16/05/2024 pm IST 5-day change 1st Jan Change
2,000 ILa -2.91% Intraday chart for Kamada Ltd. -4.03% -10.19%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 960.1 924.6 920.4 615 1,280 1,150 - -
Enterprise Value (EV) 1 960.1 924.6 920.4 615 1,280 1,150 1,150 1,150
P/E ratio - - - - - - - -
Yield - - - - - - - -
Capitalization / Revenue 2.2 x 2.13 x 2.7 x 1.31 x 2.51 x 1.96 x 1.73 x 1.49 x
EV / Revenue 2.2 x 2.13 x 2.7 x 1.31 x 2.51 x 1.96 x 1.73 x 1.49 x
EV / EBITDA - - - - 1,48,21,198 x - - -
EV / FCF 11.5 x 22.5 x -22.1 x - -233 x 16.4 x 12.1 x 8.34 x
FCF Yield 8.72% 4.44% -4.52% - -0.43% 6.11% 8.29% 12%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 40,512 44,731 44,786 44,826 57,476 57,480 - -
Reference price 2 23.70 20.67 20.55 13.72 22.27 20.60 20.60 20.60
Announcement Date 12/02/20 10/02/21 15/03/22 15/03/23 06/03/24 - - -
1ILS in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 436.2 433.1 340.3 469.1 510.9 587.4 664.3 772.4
EBITDA - - - - 86.36 - - -
EBIT 1 78.14 62.53 -2.286 16.44 36.08 75.71 81.38 114
Operating Margin 17.91% 14.44% -0.67% 3.5% 7.06% 12.89% 12.25% 14.75%
Earnings before Tax (EBT) 1 78.81 60.35 -6.19 -8.192 30.22 69.75 77.9 110.1
Net income 1 76.31 55.72 -7.323 -8.417 29.7 55.1 66.75 93.97
Net margin 17.49% 12.86% -2.15% -1.79% 5.81% 9.38% 10.05% 12.17%
EPS - - - - - - - -
Free Cash Flow 1 83.7 41.06 -41.62 - -5.499 70.22 95.3 137.8
FCF margin 19.19% 9.48% -12.23% - -1.08% 11.95% 14.35% 17.84%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 109.69% 73.69% - - - 127.43% 142.77% 146.64%
Dividend per Share - - - - - - - -
Announcement Date 12/02/20 10/02/21 15/03/22 15/03/23 06/03/24 - - -
1ILS in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 103.3 95.31 76.9 111.8 164.8 113.6 140.1 146.1 130.6 140.3 144.8 147.7 154.1
EBITDA - - - - - - - - - - - - -
EBIT 1 -10.84 0.8346 -7.478 8.893 14.57 1.069 9.846 16.82 9.951 15.01 13.17 13.05 34.45
Operating Margin -10.49% 0.88% -9.72% 7.95% 8.84% 0.94% 7.03% 11.51% 7.62% 10.7% 9.09% 8.84% 22.36%
Earnings before Tax (EBT) 1 -15.32 -6.063 -12.75 1.715 10.68 -6.641 7.129 12.69 18.01 9.065 13.17 13.05 34.45
Net income 1 -16.45 -6.202 -12.78 1.68 10.68 -6.689 6.781 12.41 18.13 8.79 10.4 10.31 27.21
Net margin -15.92% -6.51% -16.62% 1.5% 6.48% -5.89% 4.84% 8.5% 13.88% 6.27% 7.18% 6.98% 17.66%
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 15/03/22 17/05/22 17/08/22 22/11/22 15/03/23 24/05/23 16/08/23 13/11/23 06/03/24 08/05/24 - - -
1ILS in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 83.7 41.1 -41.6 - -5.5 70.2 95.3 138
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 7.89 17.9 12.2 13.7 21 1.81 1.45 1.15
Capex / Sales 1.81% 4.12% 3.59% 2.93% 4.1% 0.31% 0.22% 0.15%
Announcement Date 12/02/20 10/02/21 15/03/22 15/03/23 06/03/24 - - -
1ILS in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. KMDA Stock
  4. Financials Kamada Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW